Skip to content
Metaboliq
Menu

Insulin resistance

Normal sugar report, and still something going on

It is one of the most common sentences a doctor hears: my sugar was normal, so nothing was explained to me. Both halves of that sentence can be accurate at the same time, and the gap between them is where most of the useful information sits.

Not yet reviewed by a clinician

Nobody has signed this page off, so no name and no registration number are shown. We would rather say that than print one you cannot check. Every source below is named and linked in the meantime, so you can read them and disagree with us. The standard a reviewed page is held to is set out on our review standard page.

Published 15 August 2026 · Last updated 15 August 2026

Part of Insulin resistance.

A normal reading is an outcome, not a mechanism

Fasting glucose describes where the blood sugar has settled. It says nothing about the effort behind that settling. If cells respond less readily to insulin, the pancreas can raise output and hold the glucose reading in the usual range, and the report will describe a system that is succeeding without describing the cost of the success.

This compensation has been measured directly rather than inferred: insulin secretion rises as sensitivity falls, and the relationship is close enough that the glucose reading can stay unremarkable through a substantial change. That is not a loophole in the test. It is the test doing exactly what it measures.

Sources: [1]

The long quiet phase before anything shows

Reviews of how type 2 diabetes develops describe a prolonged period during which the underlying changes are already present and the conventional markers have not yet moved. That period is not brief and it is not symptomatic in a way anyone reliably notices. It is the reason a diagnosis so often arrives as a surprise to somebody whose annual reports were fine.

It is also the reason the intermediate states are defined at all. The bands between clearly normal and clearly diabetic exist precisely because the transition is gradual, and the definitions of those bands differ between guideline bodies — which tells you something honest about how much of a continuum this is underneath the categories.

Sources: [2], [3]

The trajectory is not fixed. A substantial proportion of people in an intermediate band revert to normal on retesting, and reviews of the field say so plainly rather than presenting the direction as inevitable.

What actually gets measured instead

Fasting insulin alongside fasting glucose describes the effort as well as the outcome. HbA1c describes the average over the preceding weeks rather than one morning. An oral glucose tolerance test describes what happens under load rather than at rest, which is where some people's difficulty first appears. Between them, these describe three different questions, and a standard package usually asks only the cheapest of them.

Around them sit the markers that often move earlier than glucose does: the pattern of the lipid panel, liver enzymes, and a waist measurement taken properly. The reason to look at those together is that they are the same story told from different angles, and any one of them alone is easy to dismiss.

Sources: [3], [4]

Why this is a particularly Indian problem

India's largest metabolic survey found prediabetes and abdominal obesity at a scale that routine testing was not detecting early, with a substantial share undiagnosed at the point of survey. In a population where the intermediate state is that common, a screening approach built on one fasting glucose value is going to reassure a large number of adults who would benefit from a longer look.

There is also a body-composition dimension, dealt with separately on this site, in which metabolic risk appears at body weights that would be considered unremarkable elsewhere. The practical upshot is the same: appearing well and reporting a normal sugar are two forms of reassurance that are frequently accurate and are not equivalent to having been looked at properly.

Sources: [4]

What symptoms do and do not tell you

People who eventually turn out to have reduced insulin sensitivity often describe the same handful of experiences: heaviness an hour or two after a large rice or roti meal, hunger returning much sooner than the meal size suggests it should, and darkened skin at the back of the neck or in the armpits. Those are worth mentioning to a doctor, because they change which tests get ordered.

They are not, however, a diagnosis, and this is the point at which a lot of online material overreaches. Every one of those experiences has several other explanations, some of them entirely benign and some of them worth investigating for completely different reasons. Symptoms are a reason to measure. They are not a substitute for measuring.

Sources: [2]

What to do with a normal report you do not believe

Keep it. A normal result is genuinely good information and it becomes more useful over time, because the comparison that matters most later is against your own earlier values in the same laboratory. Then ask for the markers the package left out, rather than repeating the one it included.

And be specific about the question. 'Is my sugar okay' has already been answered. 'Is my glucose normal because my metabolism is comfortable, or because it is compensating' is a different question, it needs different markers, and it is a question a doctor can actually work with.

Sources: [1]

Where this comes from

Every source, in full

Linked to the publisher or to the abstract, so you can read them and disagree with us.

  1. [1] Ferrannini E, Natali A, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)

    Journal of Clinical Investigation, 1997. Insulin secretion rises to compensate for reduced sensitivity, which is why glucose can remain in the usual range for years while insulin output has already changed substantially.

    Read the source
  2. [2] Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes

    The Lancet, 2017. A general review of type 2 diabetes: the long asymptomatic phase before diagnosis, and the progressive nature of the underlying changes in insulin secretion and sensitivity.

    Read the source
  3. [3] Tabák AG, et al. Prediabetes: a high-risk state for diabetes development

    The Lancet, 2012. Reviews the intermediate states between normal glucose handling and diabetes, the variation between definitions, and the fact that the trajectory is not fixed in either direction.

    Read the source
  4. [4] Anjana RM, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

    The Lancet Diabetes & Endocrinology, 2023. The national survey of diabetes, prediabetes, abdominal obesity and dyslipidaemia across Indian states, and the scale of prediabetes that had not been diagnosed at the time of survey.

    Read the source

One next step

Health assessment

The question a normal sugar report leaves open is answerable, but only with the markers that report did not include and a doctor to read them together.

₹1,799blood_panel_45_markers, home_collection, doctor_review, eligibility_decision, personalised_plan_day_3. Provided by Metaboliq with a partnered NABL-accredited laboratory.

Related reading

These answer the question next to this one

Because almost nobody arrives with exactly one question.